0000899243-19-001927.txt : 20190124
0000899243-19-001927.hdr.sgml : 20190124
20190124202526
ACCESSION NUMBER: 0000899243-19-001927
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190122
FILED AS OF DATE: 20190124
DATE AS OF CHANGE: 20190124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hatfield Jeffrey S.
CENTRAL INDEX KEY: 0001609879
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36510
FILM NUMBER: 19541048
MAIL ADDRESS:
STREET 1: 11080 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZAFGEN, INC.
CENTRAL INDEX KEY: 0001374690
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203857670
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 175 PORTLAND STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02114
BUSINESS PHONE: 617-622-4003
MAIL ADDRESS:
STREET 1: 175 PORTLAND STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02114
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN INC
DATE OF NAME CHANGE: 20060906
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-22
0
0001374690
ZAFGEN, INC.
ZFGN
0001609879
Hatfield Jeffrey S.
C/O ZAFGEN, INC.
175 PORTLAND STREET, 4TH FLOOR
BOSTON
MA
02114
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
4.63
2019-01-22
4
A
0
525000
0.00
A
2029-01-22
Common Stock
525000
525000
D
25% of this option vests on January 22, 2020, and the remainder vests in equal monthly installments thereafter over 36 months.
/s/ Shoaib Ghias, attorney-in-fact
2019-01-24